Literature DB >> 24072452

Unilateral ureteral obstruction: beyond obstruction.

Alvaro C Ucero1, Alberto Benito-Martin, Maria C Izquierdo, Maria D Sanchez-Niño, Ana B Sanz, Adrian M Ramos, Sergio Berzal, Marta Ruiz-Ortega, Jesus Egido, Alberto Ortiz.   

Abstract

Unilateral ureteral obstruction is a popular experimental model of renal injury. However, the study of the kidney response to urinary tract obstruction is only one of several advantages of this model. Unilateral ureteral obstruction causes subacute renal injury characterized by tubular cell injury, interstitial inflammation and fibrosis. For this reason, it serves as a model both of irreversible acute kidney injury and of events taking place during human chronic kidney disease. Being a unilateral disease, it is not useful to study changes in global kidney function, but has the advantage of a low mortality and the availability of an internal control (the non-obstructed kidney). Experimental unilateral ureteral obstruction has illustrated the molecular mechanisms of apoptosis, inflammation and fibrosis, all three key processes in kidney injury of any cause, thus providing information beyond obstruction. Recently this model has supported key concepts on the role in kidney fibrosis of epithelial-mesenchymal transition, tubular epithelial cell G2/M arrest, the anti-aging hormone Klotho and renal innervation. We now review the experimental model and its contribution to identifying novel therapeutic targets in kidney injury and fibrosis, independently of the noxa.

Entities:  

Mesh:

Year:  2013        PMID: 24072452     DOI: 10.1007/s11255-013-0520-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  134 in total

1.  Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.

Authors:  Alejandro Álvarez-Prats; Octavio Hernández-Perera; Pilar Díaz-Herrera; Álvaro C Ucero; Aránzazu Anabitarte-Prieto; Antonio Losada-Cabrera; Alberto Ortiz; José C Rodríguez-Pérez
Journal:  Nephrol Dial Transplant       Date:  2012-02-01       Impact factor: 5.992

2.  Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy.

Authors:  H Kaneto; H Ohtani; A Fukuzaki; S Ishidoya; A Takeda; Y Ogata; H Nagura; S Orikasa
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

3.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Michael Frink; Yvonne Linde; Clemens D Cohen; Simone M Blattner; Matthias Kretzler; Frank Strutz; Matthias Mack; Hermann-Josef Gröne; James Onuffer; Richard Horuk; Peter J Nelson; Detlef Schlöndorff
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

Authors:  T Oda; Y O Jung; H S Kim; X Cai; J M López-Guisa; Y Ikeda; A A Eddy
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

5.  Late renal failure due to prostatic outflow obstruction: a preventable disease.

Authors:  S H Sacks; S A Aparicio; A Bevan; D O Oliver; E J Will; A M Davison
Journal:  BMJ       Date:  1989-01-21

6.  CD4+ T Lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis.

Authors:  Lili Liu; Pei Kou; Qiao Zeng; Guangchang Pei; Yueqiang Li; Huifang Liang; Gang Xu; Sheng Chen
Journal:  Am J Nephrol       Date:  2012-10-09       Impact factor: 3.754

Review 7.  Tight junction biology and kidney dysfunction.

Authors:  David B N Lee; Edmund Huang; Harry J Ward
Journal:  Am J Physiol Renal Physiol       Date:  2006-01

8.  Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney.

Authors:  H Kaneto; J Morrissey; R McCracken; A Reyes; S Klahr
Journal:  Kidney Int       Date:  1994-06       Impact factor: 10.612

9.  Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

Authors:  Vanesa Esteban; Oscar Lorenzo; Mónica Rupérez; Yusuke Suzuki; Sergio Mezzano; Julia Blanco; Mathias Kretzler; Takeshi Sugaya; Jesús Egido; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

10.  Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis.

Authors:  J R Diamond; D Kees-Folts; S D Ricardo; A Pruznak; M Eufemio
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

View more
  58 in total

1.  Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.

Authors:  Beatriz Suarez-Alvarez; José Luis Morgado-Pascual; Sandra Rayego-Mateos; Ramon M Rodriguez; Raul Rodrigues-Diez; Pablo Cannata-Ortiz; Ana B Sanz; Jesus Egido; Pierre-Louis Tharaux; Alberto Ortiz; Carlos Lopez-Larrea; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

2.  Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.

Authors:  Anders Nordholm; Maria L Mace; Eva Gravesen; Jacob Hofman-Bang; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

3.  The effect of epigallocatechin-3-gallate on the renal dysfunction in the obstructed kidney in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-09-01

4.  Renoprotective effect of platelet-rich plasma in obstructive uropathy.

Authors:  Emrah Özsoy; Musab Ali Kutluhan; Mehmet Akyüz; Emre Tokuç; Ahmet Ürkmez; Gülistan Gümrükçü; Metin İshak Öztürk
Journal:  Int Urol Nephrol       Date:  2021-01-29       Impact factor: 2.370

5.  TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.

Authors:  Sandra Rayego-Mateos; Jose Luis Morgado-Pascual; José Manuel Valdivielso; Ana Belén Sanz; Enrique Bosch-Panadero; Raúl R Rodrigues-Díez; Jesús Egido; Alberto Ortiz; Emilio González-Parra; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2020-07-06       Impact factor: 10.121

Review 6.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

7.  Factors determining renal impairment in unilateral ureteral colic secondary to calcular disease: a prospective study.

Authors:  Ammar Al-Ani; Khaled Al-Jalham; Tarek Ibrahim; Ahmad Majzoub; Maged Al-Rayashi; Ahmed Hayati; Walid Mubarak; Jehan Al-Rayahi; Ahmed T Khairy
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

8.  Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs.

Authors:  Jie Song; Yangyang Xia; Xiang Yan; Jia Luo; Chunming Jiang; Miao Zhang; Guo-Ping Shi; Wei Zhu
Journal:  Int Urol Nephrol       Date:  2019-08-10       Impact factor: 2.370

9.  Effect of erythropoietin on the expression of dynamin-related protein-1 in rat renal interstitial fibrosis.

Authors:  Xian-Feng Zhao; Yan-Hong Liu; Zi-Ming Han; Y U Xu
Journal:  Exp Ther Med       Date:  2015-04-09       Impact factor: 2.447

10.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.